Free Newsletter
Wyeth pulls cold remedies for kids
Here's a perfect example of the dose-related confusion that has pediatrics experts calling for action against cold meds for kids: More than a half dozen Wyeth products now on store shelves have dosage cups that lack the mark for a half-teaspoon. That's the proper amount for children 2 to 5. The Robitussin and Dimetapp products won't be on shelves for long, though. Wyeth is recalling them to replace their cups with an updated version.
Just three weeks ago, drug makers recalled cold and cough meds for kids under two. Then, an FDA advisory committee hashed over safety and efficacy of these remedies for kids under six--and finally concluded that they shouldn't be used. The agency is now deciding what comes next.
- take a look at this news release from Wyeth
- read the AP article
Related Articles:
FDA panel: No cold meds for under-6 kids. Report
FDA experts mull ban on child cold meds. Report
Drug makers recall infant cold meds. Report
FDA to review OTC cough medicine safety. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: